Related references
Note: Only part of the references are listed.Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Contralateral Risk-Reducing Mastectomy: Review of Risk Factors and Risk-Reducing Strategies
N. N. Basu et al.
INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY (2015)
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis
Antonis Valachis et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
Kelly Metcalfe et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services
D. Gareth R. Evans et al.
BREAST CANCER RESEARCH (2014)
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer
D. Gareth R. Evans et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kelly-Anne Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
Fergus J. Couch et al.
PLOS GENETICS (2013)
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk
Mia M. Gaudet et al.
PLOS GENETICS (2013)
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study
Kerstin Rhiem et al.
BREAST CANCER RESEARCH (2012)
Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
D. G. R. Evans et al.
BRITISH JOURNAL OF CANCER (2010)
Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction
Antonis C. Antoniou et al.
CANCER RESEARCH (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Genome-wide association study identifies five new breast cancer susceptibility loci
Clare Turnbull et al.
NATURE GENETICS (2010)
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Monika K. Graeser et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting:: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
D. Gareth Evans et al.
BMC CANCER (2008)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
LJ Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers:: an update
J Gronwald et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers:: a case-control study
SA Narod et al.
LANCET (2000)
Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
LC Verhoog et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
